PRR11 unveiled as a top candidate biomarker within the RBM3‐regulated transcriptome in pancreatic cancer

Abstract The outlook for patients with pancreatic cancer remains dismal. Treatment options are limited and chemotherapy remains standard of care, leading to only modest survival benefits. Hence, there is a great need to further explore the mechanistic basis for the intrinsic therapeutic resistance o...

Full description

Bibliographic Details

Published in:	The Journal of Pathology: Clinical Research
Main Authors:	Sofie Olsson Hau, Sara Wahlin, Sophie Cervin, Vilgot Falk, Björn Nodin, Jacob Elebro, Jakob Eberhard, Bruce Moran, William M Gallagher, Emelie Karnevi, Karin Jirström
Format:	Article
Language:	English
Published:	Wiley 2022-01-01
Subjects:	cyclin D3 pancreatic cancer PDS5A prognosis PRR11 RBM3‐regulated genes
Online Access:	https://doi.org/10.1002/cjp2.238